Evolution of reproductive control program for dogs and cats, held at Unesp, Jaboticabal-SP, from 2007 to 2014 / Evolução do programa de controle reprodutivo de cães e gatos realizado na Unesp, Campus de JaboticabalSP, no período de 2007 a 2014

The population control of dogs and cats is a public healthconcern. This report describes the activities of the AcademicExtension of the College of Agricultural and VeterinarySciences of UNESP in Jaboticabal/SP - Brazil aimed at surgicalsterilization of stray dogs and cats, with social actionsrelated to teaching and research. In 2007, the first yearof the project, 129 pets were sterilized, whereas in 2014,between January and October, 1538 animals were sterilized,which shows the increase in program acceptance by thelocal community. All the activities carried out contributedtowards the academic and professional training of studentsof the extension project, as well as residents participating inthe program. It can be concluded that the development ofsurgical sterilization programs of dogs and cats by educationalinstitutions, combining research, teaching, and extensionpractices, is a viable option for veterinary medicine teachingpractices.(AU)

O controle da população de cães e gatos é uma preocupaçãopara a saúde pública. Este relato descreve as atividades realizadasno Projeto de Extensão da Faculdade de Ciências Agrárias eVeterinárias da Universidade Estadual Paulista "Júlio de MesquitaFilho" (UNESP) de Jaboticabal, localizada no Estado de São Paulo,Brasil, que visou à esterilização cirúrgica de cães e gatos, comações sociais aliadas ao ensino e pesquisa. Em 2007, ano de implantaçãodo projeto, foram esterilizados 129 animais; já no anode 2014, entre os meses de janeiro e outubro, foram esterilizados1.538 animais, o que demonstra a evolução e aceitação do programapela sociedade local. Toda a atividade realizada colaboroupara a formação acadêmica e profissional dos alunos do projetode extensão, bem como residentes participantes do programa.Pode-se concluir que o desenvolvimento de programas para aesterilização de cães e gatos, em conjunto com instituições educacionais,aliando pesquisa às práticas de ensino e extensão, é uma opção viável para as práticas de ensino em Medicina Veterinária.(AU)

Evolution of reproductive control program for dogs and cats, held at Unesp, Jaboticabal-SP, from 2007 to 2014 / Evolução do programa de controle reprodutivo de cães e gatos realizado na Unesp, Campus de JaboticabalSP, no período de 2007 a 2014

The population control of dogs and cats is a public healthconcern. This report describes the activities of the AcademicExtension of the College of Agricultural and VeterinarySciences of UNESP in Jaboticabal/SP - Brazil aimed at surgicalsterilization of stray dogs and cats, with social actionsrelated to teaching and research. In 2007, the first yearof the project, 129 pets were sterilized, whereas in 2014,between January and October, 1538 animals were sterilized,which shows the increase in program acceptance by thelocal community. All the activities carried out contributedtowards the academic and professional training of studentsof the extension project, as well as residents participating inthe program. It can be concluded that the development ofsurgical sterilization programs of dogs and cats by educationalinstitutions, combining research, teaching, and extensionpractices, is a viable option for veterinary medicine teachingpractices.

O controle da população de cães e gatos é uma preocupaçãopara a saúde pública. Este relato descreve as atividades realizadasno Projeto de Extensão da Faculdade de Ciências Agrárias eVeterinárias da Universidade Estadual Paulista "Júlio de MesquitaFilho" (UNESP) de Jaboticabal, localizada no Estado de São Paulo,Brasil, que visou à esterilização cirúrgica de cães e gatos, comações sociais aliadas ao ensino e pesquisa. Em 2007, ano de implantaçãodo projeto, foram esterilizados 129 animais; já no anode 2014, entre os meses de janeiro e outubro, foram esterilizados1.538 animais, o que demonstra a evolução e aceitação do programapela sociedade local. Toda a atividade realizada colaboroupara a formação acadêmica e profissional dos alunos do projetode extensão, bem como residentes participantes do programa.Pode-se concluir que o desenvolvimento de programas para aesterilização de cães e gatos, em conjunto com instituições educacionais,aliando pesquisa às práticas de ensino e extensão, é uma opção viável para as práticas de ensino em Medicina Veterinária.

Ação anestésica e oftálmica da administração de colírio de tetracaína 1 por cento e proparacaína 05 por cento em cães / Ophthalmic and anesthetic evaluation of topical 1 percent tetracaine and 0.5 percent proparacaine in dogs

The aim of this study was to establish the action of 1 percent tetracaine eye drops in combination with 0.1 percent phenylephrine in two different posologies and their effects on the eye compared to the 0.5 percent proparacaine drops in dogs. 22 animals were divided into two groups: TG (11 animals), received 1 percent tetracaine associated with 0.1 percent phenylephrine eye drops, one drop instilled in the left eye and two drops, with one-minute interval between each, instilled in the right eye; PG (11 animals) received 0.5 percent proparacaine eye drops following the same dosage. The average duration of the observed anesthetic action was 25 minutes for tetracaine and 15 minutes for proparacaine. The instillation of two drops increased anesthetic time in five minutes. No changes in intraocular pressure, pupil diameter and tear production was observed. The drops of tetracaine triggered chemosis in four (36.4 percent) animals. Topical anesthesia with proparacaine eye drops showed no adverse reactions and is thus recommended preferentially.(AU)

Estudou-se a ação do colírio de tetracaína 1 por cento, em associação com a fenilefrina 0,1 por cento em duas posologias diferenciadas, bem como seus efeitos oculares, comparando-a com a do colírio de proparacaína 0,5 por cento em cães. Vinte e dois animais foram separados em dois grupos. Os do GT (n=11) receberam colírio de tetracaína 1 por cento associada à fenilefrina 0,1 por cento, sendo uma gota instilada no olho esquerdo e duas gotas, com intervalo de um minuto entre cada, instiladas no olho direito; e os do GP (n=11), receberam colírio de proparacaína 0,5 por cento seguindo a mesma posologia. A média de duração da ação anestésica observada foi de 25 minutos para a tetracaína e 15 minutos para a proparacaína. A instilação de duas gotas aumentou o tempo anestésico em cinco minutos. Não ocorreram alterações na pressão intra-ocular, no diâmetro pupilar e na produção lacrimal. O colírio de tetracaína desencadeou quemose em quatro (36,4 por cento) animais. Na anestesia tópica do olho com proparacaína não ocorreram reações adversas sendo, assim, recomendada preferencialmente.(AU)

Ophthalmic and anesthetic evaluation of topical 1 percent tetracaine and 0.5 percent proparacaine in dogs / Ação anestésica e oftálmica da administração de colírio de tetracaína 1 por cento e proparacaína 0,5 por cento em cães

The aim of this study was to establish the action of 1 percent tetracaine eye drops in combination with 0.1 percent phenylephrine in two different posologies and their effects on the eye compared to the 0.5 percent proparacaine drops in dogs. 22 animals were divided into two groups: TG (11 animals), received 1 percent tetracaine associated with 0.1 percent phenylephrine eye drops, one drop instilled in the left eye and two drops, with one-minute interval between each, instilled in the right eye; PG (11 animals) received 0.5 percent proparacaine eye drops following the same dosage. The average duration of the observed anesthetic action was 25 minutes for tetracaine and 15 minutes for proparacaine. The instillation of two drops increased anesthetic time in five minutes. No changes in intraocular pressure, pupil diameter and tear production was observed. The drops of tetracaine triggered chemosis in four (36.4 percent) animals. Topical anesthesia with proparacaine eye drops showed no adverse reactions and is thus recommended preferentially.

Estudou-se a ação do colírio de tetracaína 1 por cento, em associação com a fenilefrina 0,1 por cento em duas posologias diferenciadas, bem como seus efeitos oculares, comparando-a com a do colírio de proparacaína 0,5 por cento em cães. Vinte e dois animais foram separados em dois grupos. Os do GT (n=11) receberam colírio de tetracaína 1 por cento associada à fenilefrina 0,1 por cento, sendo uma gota instilada no olho esquerdo e duas gotas, com intervalo de um minuto entre cada, instiladas no olho direito; e os do GP (n=11), receberam colírio de proparacaína 0,5 por cento seguindo a mesma posologia. A média de duração da ação anestésica observada foi de 25 minutos para a tetracaína e 15 minutos para a proparacaína. A instilação de duas gotas aumentou o tempo anestésico em cinco minutos. Não ocorreram alterações na pressão intra-ocular, no diâmetro pupilar e na produção lacrimal. O colírio de tetracaína desencadeou quemose em quatro (36,4 por cento) animais. Na anestesia tópica do olho com proparacaína não ocorreram reações adversas sendo, assim, recomendada preferencialmente.

Mutagenicity induced by the hydroalcoholic extract of the medicinal plant Plathymenia reticulata Benth

Plathymenia reticulata Benth has an anti-inflammatory effect and is capable of neutralizing the neuromuscular blockade induced by Bothrops jararacussu or Crotalus durissus terrificus venoms, probably by precipitating venom proteins (an effect caused by plant tannins). The present study aimed to evaluate the mutagenic activity of P. reticulata by using the Salmonella mutagenicity assay (Ames test) and the micronucleus test in CHO-K1 cells. P. reticulata extract concentrations of 2.84, 5.68, 11.37, and 19.90 mg/plate were assayed by the Ames test using TA97a, TA98, TA100 and TA102 bacterial strains, with (+S9) and without (-S9) metabolic activation. Concentrations of 5, 1.6 and 0.5 μg/mL of P. reticulata extract were used for the micronucleus test. P. reticulata extract was mutagenic to TA98 (-S9) and showed signs of mutagenic activity in TA97a and TA102 (both -S9) strains. Micronucleus test CBPI values showed that the endogenous metabolic system increased the number of viable cells when compared to the non-activated samples and the micronucleus frequency increased when the cells were treated in the absence of S9. We concluded that P. reticulata extract may present direct mutagenic properties.(AU)

Mutagenicity induced by the hydroalcoholic extract of the medicinal plant Plathymenia reticulata Benth

Plathymenia reticulata Benth has an anti-inflammatory effect and is capable of neutralizing the neuromuscular blockade induced by Bothrops jararacussu or Crotalus durissus terrificus venoms, probably by precipitating venom proteins (an effect caused by plant tannins). The present study aimed to evaluate the mutagenic activity of P. reticulata by using the Salmonella mutagenicity assay (Ames test) and the micronucleus test in CHO-K1 cells. P. reticulata extract concentrations of 2.84, 5.68, 11.37, and 19.90 mg/plate were assayed by the Ames test using TA97a, TA98, TA100 and TA102 bacterial strains, with (+S9) and without (-S9) metabolic activation. Concentrations of 5, 1.6 and 0.5 ìg/mL of P. reticulata extract were used for the micronucleus test. P. reticulata extract was mutagenic to TA98 (-S9) and showed signs of mutagenic activity in TA97a and TA102 (both -S9) strains. Micronucleus test CBPI values showed that the endogenous metabolic system increased the number of viable cells when compared to the non-activated samples and the micronucleus frequency increased when the cells were treated in the absence of S9. We concluded that P. reticulata extract may present direct mutagenic properties.

Neuromuscular activity of BaTX, a presynaptic basic PLA2 isolated from Bothrops alternatus snake venom.

We have previously isolated a Lys49 phospholipase A(2) homolog (BaTX) from Bothrops alternatus snake venom using a combination of molecular exclusion chromatography and reverse phase HPLC and shown its ability to cause neuromuscular blockade. In this work, we describe a one-step procedure for the purification of this toxin and provide further details of its neuromuscular activity. The toxin was purified by reverse phase HPLC and its purity and molecular mass were confirmed by SDS-PAGE, MALDI-TOF mass spectrometry, amino acid analysis and N-terminal sequencing. BaTX (0.007-1.4 microM) produced time-dependent, irreversible neuromuscular blockade in isolated mouse phrenic nerve-diaphragm and chick biventer cervicis preparations (time to 50% blockade with 0.35 microM toxin: 58+/-4 and 24+/-1 min, respectively; n=3-8; mean+/-S.E.) without significantly affecting the response to direct muscle stimulation. In chick preparations, contractures to exogenous acetylcholine (55 and 110 microM) or KCl (13.4 mM) were unaltered after complete blockade by all toxin concentrations. These results, which strongly suggested a presynaptic mechanism of action for this toxin, were reinforced by (1) the inability of BaTX to interfere with the carbachol-induced depolarization of the resting membrane, (2) a significant decrease in the frequency and amplitude of miniature end-plate potentials, and (3) a significant reduction (59+/-4%, n=12) in the quantal content of the end-plate potentials after a 60 min incubation with the toxin (1.4 microM). In addition, a decrease in the organ bath temperature from 37 degrees C to 24 degrees C and/or the replacement of calcium with strontium prevented the neuromuscular blockade, indicating a temperature-dependent effect possibly mediated by enzymatic activity.

Antineurotoxic activity of Galactia glaucescens against Crotalus durissus terrificus venom.

Ethanolic extract of leaves of Galactia glauscescens (GGE) at concentration of 100 and 500 microg/ml prevented the neuromuscular paralysis induced by Crotalus durissus terrificus venom on mouse phrenic nerve-diaphragm preparation.

Children and adolescents infected with Wuchereria bancrofti in Greater Recife, Brazil: a randomized, year-long clinical trial of single treatments with diethylcarbamazine or diethylcarbamazine-albendazole.

In filariasis-endemic areas beyond sub-Saharan Africa, the World Health Organization's recommended strategy for interrupting transmission of the causative parasites is annual, single-dose, mass treatment with a combination of diethylcarbamazine (DEC; given at 6 mg/kg) and albendazole (ALB; given at 400 mg) for 4-6 years (the minimum estimated life-span of the adult parasites). In an open, hospital-based, randomized and controlled trial, with a blinded evaluation of outcome, 82 children and adolescents from Recife, all with Wuchereria bancrofti microfilaraemias, were given either DEC alone (6 mg/kg) or the same dose of DEC combined with ALB (at 400 mg/patient). Every 90 days for 1 year after the single treatment, each patient was checked for microfilaraemia by the filtration of up to 5 ml of venous blood collected at night. One year post-treatment, 16 (39%) of the 41 patients given DEC alone and 20 (49%) of the 41 given DEC-ALB were found microfilaraemic (relative risk=0.8, with a 95% confidence interval of 0.49-1.31) and the corresponding geometric mean levels of microfilaraemia were 2.0% and 1.8% of the levels recorded immediately pre-treatment, respectively (P>0.05). In terms of the prevalences and intensities of microfilaraemia, therefore, the addition of ALB to the DEC appeared to offer no significant benefit.

Neuromuscular activity of Bothrops neuwiedi pauloensis snake venom in mouse nerve-muscle preparations

The pharmacological effects of Bothrops neuwiedi pauloensis venom on mouse phrenic nerve-diaphragm (PND) preparations were studied. Venom (20 mug/ml) irreversibly inhibited indirectly evoked twitches in PND preparations (60 ± 10 percent inhibition, mean ± SEM; p<0.05; n=6). At 50 mug/ml, the venom blocked indirectly and directly (curarized preparations) evoked twitches in mouse hemidiaphragms. In the absence of Ca2+, venom (50 mug/ml), produced partial blockade only after an 80 min incubation, which reached 40.3 ± 7.8 percent (p<0.05; n=3) after 120 min. Venom (20 mug/ml) increased (25 ± 2 percent, p< 0.05) the frequency of giant miniature end-plate potentials in 9 of 10 end-plates after 30 min and the number of miniature end-plate potentials which was maximum (562 ± 3 percent, p<0.05) after 120 min. During the same period, the resting membrane potential decreased from - 81 ± 1.4 mV to - 41.3 ± 3.6 mV 24 fibers; p<0.01; n=4) in the end-plate region and from - 77.4 ± 1.4 to -44.6 ± 3.9 mV (24 fibers; p<0.01; n=4) in regions distant from the end-plate. These results indicate that B. n. pauloensis venom acts primarily at presynaptic sites. They also suggest that enzymatic activity may be involved in this pharmacological action.(AU)

Neuromuscular activity of Bothrops neuwiedi pauloensis snake venom in mouse nerve-muscle preparations

The pharmacological effects of Bothrops neuwiedi pauloensis venom on mouse phrenic nerve-diaphragm (PND) preparations were studied. Venom (20 mug/ml) irreversibly inhibited indirectly evoked twitches in PND preparations (60 ± 10% inhibition, mean ± SEM; p 0.05; n=6). At 50 mug/ml, the venom blocked indirectly and directly (curarized preparations) evoked twitches in mouse hemidiaphragms. In the absence of Ca2+, venom (50 mug/ml), produced partial blockade only after an 80 min incubation, which reached 40.3 ± 7.8% (p 0.05; n=3) after 120 min. Venom (20 mug/ml) increased (25 ± 2%, p 0.05) the frequency of giant miniature end-plate potentials in 9 of 10 end-plates after 30 min and the number of miniature end-plate potentials which was maximum (562 ± 3%, p 0.05) after 120 min. During the same period, the resting membrane potential decreased from - 81 ± 1.4 mV to - 41.3 ± 3.6 mV 24 fibers; p 0.01; n=4) in the end-plate region and from - 77.4 ± 1.4 to -44.6 ± 3.9 mV (24 fibers; p 0.01; n=4) in regions distant from the end-plate. These results indicate that B. n. pauloensis venom acts primarily at presynaptic sites. They also suggest that enzymatic activity may be involved in this pharmacological action.

The study of tuberculosis-attributed deaths as a tool for disease control planning in Rio de Janeiro, Brazil.

SETTING: Two tuberculosis (TB) reference hospitals and three general hospitals in Rio de Janeiro (RJ). OBJECTIVE: To analyze TB-attributed deaths as a tool for evaluating the TB control program in RJ. DESIGN: Retrospective study based on 302 medical records selected from the 1998 death database. RESULTS: Of 1146 registered adult (>14 years) TB-attributed deaths in RJ, 328 occurred in five hospitals, and 302 records were analyzed. Median age was 47.5 (17-89) years; 237 (78.5%) were male. Median time elapsed from onset of symptoms until diagnosis was 60 (7-730) days; median hospitalization was 60 (0-517) days. Acid-fast bacilli sputum smears were performed in 200 (69%) of 290 cases of pulmonary disease. Among 32 (36%) smear-negative patients, culture was done in only one. The recommended regimen (RHZ) was used in 175 (58%). Among 125 re-treatment patients, 55 (44%) were on RHZ instead of RHZE. Notification to health authorities was recorded in 131 (43.4%) cases. CONCLUSION: In RJ, young people die from TB. Major issues identified in the public health system were poor detection and notification and a high default rate, perpetuating the spread of TB. Treating professionals do not follow guidelines, and political commitment is needed to ensure TB control in the state and in the country.